Facebook tracking pixel
R71.8
ICD-10-CM
Abnormal Red Blood Cells

Learn about abnormal red blood cells (RBC morphology abnormalities) including erythrocyte disorders. Find information on diagnosis, clinical documentation, and medical coding for abnormal RBCs. This resource provides healthcare professionals with key insights into identifying and documenting red blood cell morphology abnormalities for accurate medical coding and improved patient care.

Also known as

RBC Morphology Abnormalities
Erythrocyte Disorders

Diagnosis Snapshot

Key Facts
  • Definition : Red blood cells are abnormally shaped or sized, impacting their function.
  • Clinical Signs : Anemia, fatigue, jaundice, shortness of breath, splenomegaly.
  • Common Settings : Primary care, hematology, oncology, inherited blood disorders clinics.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC R71.8 Coding
D55-D59

Hereditary hemolytic anemias

Inherited disorders causing red blood cell destruction.

D60-D64

Aplastic and other anemias

Conditions affecting red blood cell production or survival.

D70-D77

Other disorders of blood and blood-forming organs

Various blood conditions not classified elsewhere.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the abnormality due to hereditary spherocytosis?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Abnormal appearance of red blood cells.
Iron deficiency anemia.
Vitamin B12 deficiency anemia.

Documentation Best Practices

Documentation Checklist
  • Document specific RBC morphology abnormalities (e.g., poikilocytosis, anisocytosis).
  • Quantify abnormal RBCs (e.g., percentage, severity).
  • Correlate findings with clinical picture and other lab results.
  • Specify diagnostic tests performed (e.g., peripheral blood smear).
  • Document any associated symptoms or underlying conditions.

Coding and Audit Risks

Common Risks
  • Unspecified Anemia Coding

    Coding anemia as unspecified (D64.9) without documenting specific morphology findings like sickle cell or spherocytosis risks downcoding and lost revenue.

  • RBC Morphology Overcoding

    Coding multiple RBC morphology abnormalities when only one clinically significant condition is present leads to overcoding and potential audits.

  • Lacking Clinical Validation

    Diagnosing 'Abnormal Red Blood Cells' without specific lab results or clinical validation in documentation can cause claim denials for insufficient documentation.

Mitigation Tips

Best Practices
  • Document RBC morphology specifics for accurate ICD-10 coding (e.g., poikilocytosis, anisocytosis).
  • Ensure precise CDI of anemia type (e.g., iron deficiency, sickle cell) for proper reimbursement.
  • Review peripheral blood smear results for abnormal RBCs and correlate with clinical findings.
  • Monitor patient hemoglobin, hematocrit, and RBC indices for trending and appropriate interventions.
  • Follow established guidelines for anemia management and ensure compliance with quality metrics.

Clinical Decision Support

Checklist
  • Review peripheral blood smear: RBC morphology
  • Correlate with CBC: RBC indices (MCV, MCH, MCHC)
  • Assess patient history: Anemia, bleeding, jaundice
  • Consider underlying conditions: Iron deficiency, hemolysis

Reimbursement and Quality Metrics

Impact Summary
  • Reimbursement Impact: Accurate coding for Abnormal Red Blood Cells (A) / RBC Morphology Abnormalities / Erythrocyte Disorders impacts appropriate DRG assignment and payment.
  • Quality Metrics Impact: Documentation of RBC morphology influences anemia management quality metrics and hospital performance reporting.
  • Coding Accuracy Impact: Precise ICD-10 coding for specific erythrocyte disorders affects data integrity for quality measurement and research.
  • Hospital Reporting Impact: Standardized coding ensures consistent reporting on RBC abnormalities, contributing to national health statistics.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the key differentiating features between common abnormal red blood cell morphologies like spherocytes, schistocytes, and target cells in a peripheral blood smear?

A: Differentiating abnormal red blood cell (RBC) morphologies on a peripheral blood smear requires careful observation of key features. Spherocytes, lacking central pallor, suggest hereditary spherocytosis or autoimmune hemolytic anemia. Schistocytes, fragmented RBCs, indicate microangiopathic hemolytic anemias like thrombotic thrombocytopenic purpura (TTP) or disseminated intravascular coagulation (DIC). Target cells, with a central hemoglobinized area, are associated with thalassemias, liver disease, or hemoglobinopathies. Accurate identification hinges on integrating these morphological findings with the patient's clinical presentation and other laboratory data. Consider implementing a standardized approach to peripheral blood smear review to improve diagnostic accuracy. Explore how advanced imaging techniques can further aid in characterizing RBC abnormalities.

Q: How can I effectively interpret abnormal red blood cell morphology findings in the context of a patient's complete blood count (CBC) and clinical picture to arrive at a differential diagnosis?

A: Integrating abnormal RBC morphology with CBC parameters and clinical context is crucial for accurate diagnosis. For example, microcytic hypochromic RBCs with target cells seen on the smear, coupled with a low MCV and MCH on the CBC, strongly suggest thalassemia. Conversely, macrocytic RBCs with hypersegmented neutrophils, combined with an elevated MCV and a clinical picture of B12 deficiency, point towards megaloblastic anemia. Furthermore, the presence of spherocytes with an elevated reticulocyte count and evidence of hemolysis (e.g., elevated LDH, decreased haptoglobin) suggests a hemolytic anemia. Correlating all these elements helps narrow the differential diagnosis and guides further investigations. Learn more about incorporating automated hematology analyzer flags and expert consultation in your diagnostic workflow.

Quick Tips

Practical Coding Tips
  • Code RBC morphology specifics
  • Document abnormal RBC details
  • Check ICD-10 for anemia codes
  • Consider size and shape terms
  • Review smear results in notes

Documentation Templates

Patient presents with signs and symptoms suggestive of abnormal red blood cell morphology.  Clinical findings include [insert specific findings e.g., fatigue, pallor, shortness of breath, splenomegaly].  Laboratory evaluation reveals [insert specific lab values e.g., low hemoglobin, decreased hematocrit, abnormal red blood cell indices such as MCV, MCH, MCHC].  Peripheral blood smear examination demonstrates [describe observed abnormalities e.g., poikilocytosis, anisocytosis, spherocytosis, elliptocytosis, target cells, sickle cells, schistocytes, Howell-Jolly bodies, basophilic stippling].  These findings are consistent with a diagnosis of abnormal red blood cells, also known as erythrocyte disorders or RBC morphology abnormalities.  Differential diagnosis includes [list relevant differential diagnoses e.g., iron deficiency anemia, thalassemia, hereditary spherocytosis, autoimmune hemolytic anemia, sickle cell disease, vitamin B12 deficiency, folate deficiency].  Further investigation may include [list additional tests e.g., iron studies, hemoglobin electrophoresis, vitamin B12 and folate levels, direct antiglobulin test, bone marrow biopsy].  Initial treatment plan includes [outline treatment plan e.g., iron supplementation, blood transfusion, folic acid supplementation, vitamin B12 injections, referral to hematologist].  Patient education provided regarding the nature of the condition, potential complications, and importance of follow-up care.  ICD-10 code [insert appropriate ICD-10 code e.g., D58.8, D58.9] and relevant CPT codes [insert relevant CPT codes for performed procedures e.g., 85025, 85027] documented for billing and coding purposes.  Prognosis and plan for ongoing monitoring will be discussed at the next appointment.